1. Sign our petition calling on Cochrane to withdraw their review of Exercise Therapy for CFS here.
    Dismiss Notice
  2. Guest, the 'News in Brief' for the week beginning 19th February 2024 is here.
    Dismiss Notice
  3. Welcome! To read the Core Purpose and Values of our forum, click here.
    Dismiss Notice

Rituximab biomarker study update

Discussion in 'ME/CFS research news' started by Ron, Mar 28, 2018.

  1. Ron

    Ron Established Member (Voting Rights)


    "Last year, we reported on a newly funded study aimed at developing a biomarker to help predict patients who will respond to treatment with rituximab. Unfortunately, this study will not now be going ahead."

    "Although we are still waiting for publication of the full trial results, it is likely they will not show any benefit of rituximab in ME/CFS patients. With this in mind, Prof. Patrick and ME Research UK jointly made the decision not to proceed with the immunosignature study since, in these trial patients at least, there would be nothing to show."

Share This Page